共 19 条
[1]
Flowcytometry analysis of platelet cyclooxygenase-2 expression:induction of platelet cyclooxygenase-2 in patients under-going coronary artery bypass grafting. Weber AA,Przytulski B,Schumacher M,et al. British Journal of Haematology . 2002
[2]
Aspi-rin response and failure in cerebral infarction. Helgason CM,Tortorice KL,Winkler SR,et al. Stroke . 1993
[3]
Resistancein vitroto low-dose aspirin is associated with plateletPlA1(GP IIIa)polymorphism but not with C807T(GPIa/IIa)and C-5T Kozak(GP Ibalpha)polymorphisms. Macchi L,Christiaens L,Brabant S,et al. Journal of the American College of Cardiology . 2003
[4]
Platelet inhibi-tion by aspirin is diminished in patients during carotidsurgery:a form of transient aspirin resistance. Payne DA,Jones CI,Hayes PD,et al. Thrombosis and Haemostasis . 2004
[5]
Resistanceto aspirinin vitrois associated with increased plateletsensitivity to adenosine diphosphate. Macchi L,Christiaens L,Brabant S,et al. Thrombosis Research . 2002
[6]
Profile and prevalence of aspirin resistance in patientswith cardiovascular disease. Gum PA,Kottke-Marchant K,Poggio ED,et al. The American Journal of Cardiology . 2001
[7]
Cyclooxyge-nase-2 expression is induced during human megakaryo-poiesis and characterizes newly formed platelets. Rocca B,Secchiero P,Ciabattoni G,et al. Proceedings of the National Academy of Sciences of the United States of America . 2002
[8]
Patientsexposed to rofecoxib and celecoxib have different odds ofnonfatal myocardial infarction. Kimmel SE,Berlin JA,Reilly M,et al. Annals of Internal Medicine . 2005
[9]
Collaborativemeta-analysis of randomised trials of antiplatelet therapyfor prevention of death,myocardial infarction,andstroke in high risk patients. Antithrombotic Trialists’Collaboration. British Medical Journal . 2002
[10]
Effective anti-platelet and COX-1 enzyme inhibi-tors from pungent constituents of ginger. Nurtjahja-Tjendraputra E,Ammit AJ,Roufogalis BD,et al. Thrombosis Research . 2003